Early treatment with Copaxone ‘benefits patients’
Early treatment with Copaxone ‘benefits patients’
Teva has announced new data on the safety and efficacy of Copaxone (glatiramer acetate injection) 40mg/mL in patients with relapsing forms of multiple sclerosis (MS)..... Read More - http://www.ms-uk.org/copaxone
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 2 Replies
- 1499 Views
-
Last post by NHE
-
- 0 Replies
- 1171 Views
-
Last post by frodo
-
- 0 Replies
- 1294 Views
-
Last post by frodo
-
- 0 Replies
- 1405 Views
-
Last post by NHE
-
- 0 Replies
- 1773 Views
-
Last post by DIM
-
- 0 Replies
- 1436 Views
-
Last post by frodo
-
- 0 Replies
- 1461 Views
-
Last post by NHE
-
- 0 Replies
- 2233 Views
-
Last post by frodo
-
- 5 Replies
- 13290 Views
-
Last post by gibbledygook